A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2361-2364

  Tomao, S ^a   Romiti, A ^a   Massidda, B ^a   Tionta, M ^a   Farris, A ^a   Zullo, A ^a   Brescia, A ^a   Santuari, L ^a   Frati, L ^a  

^a NONE   (Italy)

Author keywords

Clinical benefit; Gemcitabine; Pancreatic cancer; Tamoxifen

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; PYRIMIDINE DERIVATIVE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE;

AGED; AGED, 80 AND OVER; ANEMIA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; NEUTROPENIA; PANCREATIC NEOPLASMS; TAMOXIFEN; THROMBOCYTOPENIA; VOMITING;

EID: 0036335424     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pancreatic carcinoma
2. The prevalence of pain in four cancers
3. Pain and depression in patients with newly diagnosed pancreas cancer
4. Pancreatic cancer
5. Chemotherapy and adenocarcinoma of pancreas
6. Pancreatic carcinoma
7. A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
8. A phase III comparison trial of streptozocin, mitomycin, 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma
9. Cytotoxicity and antitumor activity of 2′, 2′-difluorodeoxy cytidinen
10. An extended phase II Study of gemcitabine in non-small cell lung cancer
11. An investigational new drug treatment program for patients with gemcitabine. Results for over 3000 patients with pancreatic carcinoma
12. Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil
13. Tamoxifen for the treatment of malignanties other than breast and endometrial cancer
14. Estrogen receptors proteins in malignant and fetal patients
15. Leuprolide and tamoxifen in the treatment of pancreatic cancer. A phase II study
16. Low dose octreotide and Tam in the treatment of adenocarcinomas of the pancreas
17. The beneficial efficacy of tamoxifen therapy in the patient with resected adenocarcinoma of the pancreas
18. Assessing the reliability of two toxicity scales: Implications for interpreting toxicity data
19. A combination of Gemcitabine and 5-Fluorouracil in advanced pancreatic cancer, a report from the italian group for the study of digestive tract cancer (GISCAD)
20. Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
21. Phase I-II study of Gemcitabine and fluorouracil as a continous infusion in patients with pancrestic cancer
22. Phase II trial of Gemcitabine in patients with adenocarcinoma of the pancreas
23. A phase II trial of Gemcitabine in patients with 5FU-refractary pancreas cancer